These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34890937)

  • 1. A CT-based radiomics signature for preoperative discrimination between high and low expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
    Zheng YM; Zhan JF; Yuan MG; Hou F; Jiang G; Wu ZJ; Dong C
    Eur J Radiol; 2022 Jan; 146():110093. PubMed ID: 34890937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
    Zheng YM; Yuan MG; Zhou RQ; Hou F; Zhan JF; Liu ND; Hao DP; Dong C
    Eur Radiol; 2022 Aug; 32(8):5362-5370. PubMed ID: 35298679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
    Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
    J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT radiomics nomogram for prediction of the Ki-67 index in head and neck squamous cell carcinoma.
    Zheng YM; Chen J; Zhang M; Wu ZJ; Tang GZ; Zhang Y; Dong C
    Eur Radiol; 2023 Mar; 33(3):2160-2170. PubMed ID: 36222864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics-based prediction model for outcomes of PD-1/PD-L1 immunotherapy in metastatic urothelial carcinoma.
    Park KJ; Lee JL; Yoon SK; Heo C; Park BW; Kim JK
    Eur Radiol; 2020 Oct; 30(10):5392-5403. PubMed ID: 32394281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CT-based Deep Learning Radiomics Nomogram for the Prediction of EGFR Mutation Status in Head and Neck Squamous Cell Carcinoma.
    Zheng YM; Pang J; Liu ZJ; Yuan MG; Li J; Wu ZJ; Jiang Y; Dong C
    Acad Radiol; 2024 Feb; 31(2):628-638. PubMed ID: 37481418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CT-Based Deep Learning Radiomics Nomogram to Predict Histological Grades of Head and Neck Squamous Cell Carcinoma.
    Zheng YM; Che JY; Yuan MG; Wu ZJ; Pang J; Zhou RZ; Li XL; Dong C
    Acad Radiol; 2023 Aug; 30(8):1591-1599. PubMed ID: 36460582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-energy CT-based radiomics nomogram in predicting histological differentiation of head and neck squamous carcinoma: a multicenter study.
    Li Z; Liu Z; Guo Y; Wang S; Qu X; Li Y; Pan Y; Zhang L; Su D; Yang Q; Tao X; Yue Q; Xian J
    Neuroradiology; 2022 Feb; 64(2):361-369. PubMed ID: 34860278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
    Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
    Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
    Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
    EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis.
    Xu Y; Zhu G; Maroun CA; Wu IXY; Huang D; Seiwert TY; Liu Y; Mandal R; Zhang X
    Front Immunol; 2021; 12():645170. PubMed ID: 33897693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer.
    Meißner AK; Gutsche R; Galldiks N; Kocher M; Jünger ST; Eich ML; Nogova L; Araceli T; Schmidt NO; Ruge MI; Goldbrunner R; Proescholdt M; Grau S; Lohmann P
    J Neurooncol; 2023 Jul; 163(3):597-605. PubMed ID: 37382806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral and Peritumoral Radiomics Based on Preoperative MRI for Evaluation of Programmed Cell Death Ligand-1 Expression in Breast Cancer.
    Wu Z; Lin Q; Wang H; Chen J; Wang G; Fu G; Li L; Bian T
    J Magn Reson Imaging; 2024 Aug; 60(2):588-599. PubMed ID: 37916918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
    Rebelatto MC; Midha A; Mistry A; Sabalos C; Schechter N; Li X; Jin X; Steele KE; Robbins PB; Blake-Haskins JA; Walker J
    Diagn Pathol; 2016 Oct; 11(1):95. PubMed ID: 27717372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma.
    Gong XQ; Liu N; Tao YY; Li L; Li ZM; Yang L; Zhang XM
    Sci Rep; 2023 May; 13(1):7710. PubMed ID: 37173350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT-based deep learning radiomics biomarker for programmed cell death ligand 1 expression in non-small cell lung cancer.
    Xu T; Liu X; Chen Y; Wang S; Jiang C; Gong J
    BMC Med Imaging; 2024 Jul; 24(1):196. PubMed ID: 39085788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-Based Radiomics Signature for the Preoperative Discrimination Between Head and Neck Squamous Cell Carcinoma Grades.
    Wu W; Ye J; Wang Q; Luo J; Xu S
    Front Oncol; 2019; 9():821. PubMed ID: 31544063
    [No Abstract]   [Full Text] [Related]  

  • 19. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
    Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
    J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel sub-regional radiomics model to predict immunotherapy response in non-small cell lung carcinoma.
    Peng J; Zou D; Zhang X; Ma H; Han L; Yao B
    J Transl Med; 2024 Jan; 22(1):87. PubMed ID: 38254087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.